AI assistant
Sending…
LENNAR CORP /NEW/ — Director's Dealing 2017
Feb 15, 2017
30122_dirs_2017-02-15_650e0c71-74af-49c8-9ab1-ce9d27107690.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LENNAR CORP /NEW/ (LEN, LEN.B)
CIK: 0000920760
Period of Report: 2017-02-14
Reporting Person: GERARD STEVEN L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-14 | Class A Common Stock | M | 2500 | $39.62 | Acquired | 35122 | Direct |
| 2017-02-14 | Class A Common Stock | S | 2190 | $46.07 | Disposed | 32932 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-14 | Stock Option (Right to Buy) | $39.62 | M | 2500 | Disposed | 2017-04-09 | Class A Common Stock (2500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class B Common Stock | 850 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $51.26 | 2018-04-08 | Class A Common Stock (2500) | 2500 | Direct |
Footnotes
F1: The price reflects the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranged from $46.06 to $46.08 per share. The reporting person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
More from LENNAR CORP /NEW/
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 10
Interim / Quarterly Report
2026
Apr 9
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Proxy Solicitation & Information Statement
2026
Feb 26
Director's Dealing
2026
Feb 18